What is the positive predictive value for preterm birth (<37 weeks of gestation) for a shortened cervix (<2.5 cm) found at the time of the fetal anatomical scan at 20 weeks of gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Positive Predictive Value for Preterm Birth with Shortened Cervix at 20 Weeks

For a cervical length <2.5 cm (≤25 mm) detected at the 20-week anatomical scan, the positive predictive value for preterm birth before 37 weeks of gestation is approximately 16.2%. 1

Specific PPV Data by Cervical Length Threshold

The Society for Maternal-Fetal Medicine provides precise predictive values based on cervical length cutoffs measured at 16-22 weeks of gestation (which includes the typical 20-week anatomical scan): 1

For Cervical Length ≤25 mm at 16-22 weeks:

  • PPV for PTB <37 weeks: 16.2% 1
  • PPV for PTB <32 weeks: 7.4% 1
  • Sensitivity: 8.0% 1
  • Specificity: 97.8% 1

For Cervical Length ≤20 mm at 16-22 weeks:

  • PPV for PTB <37 weeks: 15.5% 1
  • PPV for PTB <32 weeks: 8.6% 1
  • Sensitivity: 4.1% 1
  • Specificity: 98.8% 1

Clinical Interpretation

Despite the relatively modest positive predictive value of 16.2%, the high specificity (97.8%) and negative predictive value (94.7% based on symptomatic populations) make cervical length screening clinically valuable. 1, 2 This means that while most women with a short cervix will still deliver at term, the finding consistently identifies a high-risk population that benefits from intervention.

Key Clinical Points:

  • The finding of a short cervix at 20 weeks increases preterm birth risk approximately 3.5-fold (positive likelihood ratio of 3.67 for ≤25 mm). 1

  • The majority (approximately 84%) of women with cervical length ≤25 mm at 20 weeks will still deliver at term, but this represents a significantly elevated risk compared to women with normal cervical length. 1

  • For cervical lengths ≤20 mm, the Society for Maternal-Fetal Medicine strongly recommends vaginal progesterone (GRADE 1A) to reduce preterm birth risk, despite the modest PPV, because the intervention is safe and effective. 1, 3

Important Caveats

These predictive values apply specifically to nulliparous singleton gestations without prior spontaneous preterm birth. 1 Women with different risk profiles (prior preterm birth, multiple gestations) will have different predictive values.

Measurement technique is critical: These values are based on standardized transvaginal ultrasound measurements with proper technique and quality assurance. 1, 4 Transabdominal measurements are insufficient for clinical decision-making. 1, 4

The PPV increases if cervical length continues to shorten on subsequent measurements, with cervical length shortening >10 mm from the anatomical scan to a later symptomatic presentation increasing the PPV to 21.2%. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cervical length change as a predictor of preterm birth in symptomatic patients.

American journal of obstetrics & gynecology MFM, 2021

Guideline

Management of Short Cervical Length in Singleton Pregnancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cervical Canal Diameter in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.